LOGIC-C 8.1%; P = 0.66), there was a nonsignificant trend ( P = 0.081) toward a higher in-hospital mortality in the LOGIC-C group (12.8%) than in the Nurse-C group (6.6%).
← all phrases
“a nonsignificant trend”
Sighted at
p<0.1
In the literature
There was a nonsignificant trend toward improvement with PBT versus 3-dimensional CRT in maximum skin doses ( P = .081).
At the HLA-A locus, there was a nonsignificant trend toward a lower risk of relapse in the high group than the low group (HR, 0.90; P = .081).
A nonsignificant trend was observed in children with normal weight, with lower pre-bed fasting times than those with overweight/obesity ( p = 0.081).
There was a significant high correlation of ghrelin ( r = 0.411, p < 0.001) and GLP‐1 ( r = 0.576), p < 0.001) and a nonsignificant trend correlation with peptide YY ( r = 0.218, p = 0.081) in the FBF group; a nonsignificant trend correlation of ghrelin ( r = 0.254, p = 0.064); a significant high correlation of GLP‐1 in the PBF group (0.378, p = 0.006); and a significant high correlation of GLP‐1 ( r = 0.407, p = 0.029), but no correlation with ghrelin, leptin, and peptide YY in the HMS group. 4.
There was no significant effect of sex and no significant interaction between sex and chelar type on the proportion of any sensillar site type; however, there was a nonsignificant trend for females to have a higher proportion of clustered sensilla (S4 sites) than males (F 1,65 = 3.13, p = 0.081). 4.
However, after PS matching, the PS-adjusted HR showed a nonsignificant trend towards reduced incidence of MACCE during follow-up (HR: 0.58; 95% CI: 0.31-1.06; P =0.081).
Thus, in the unweighted fits, there was substantially greater within-group variability in the slopes ( p = .028) and points of subjective equality ( p < .001) of individual listeners, 2 and there was also a nonsignificant trend toward greater deviance between raw data and the fitted models, t (47) = −1.84, p = .081.
Nevertheless, at 28°C we found a nonsignificant trend for fish exiting faster when with a heterospecific (HR = 2.315 ± 2.525, p = 0.081) than when they were with a conspecific (HR = 1.378 ± 1.518, p = 0.508).
Calcimimetics-only use showed a nonsignificant trend toward lower hip fracture risk (HR 0.67, 95% CI 0.43–1.05; P = .082).
Age showed a nonsignificant trend toward higher AI use (OR 1.36; 95% CI, 0.96–1.92; p = 0.082), while female gender showed a nonsignificant trend toward lower AI use (OR 0.85; 95% CI, 0.64–1.12; p = 0.243).
None of the demographic variables, cardiovascular risk factors (including chronic kidney disease), or history of coronary disease differed significantly between positive and negative CAD patients, although prior myocardial infarction showed a nonsignificant trend toward being more frequent in the positive CAD group (33.3% vs. 0%; OR 8.71, 95% CI 0.46-165.96; p = 0.082).
Compared with the high group, the medium–low (HR: 0.58, 95% CI: 0.43–0.79, p < 0.001), and low (HR: 0.61, 95% CI: 0.44–0.84, p = 0.003) groups demonstrated significantly lower 28‐day mortality risk, while the medium–high group showed a nonsignificant trend toward reduced risk (HR: 0.76, 95% CI: 0.55–1.04, p = 0.082).
ypT stage remained an independent risk factor for both endpoints, significantly for PFS (HR 3.379; 95% CI 1.299–8.791; p = .013) and with a nonsignificant trend for OS (HR 2.326; 95% CI 0.900–6.015; p = .082). 3.5 IPTW ‐weighted analysis Following multivariable analysis, an IPTW‐weighted analysis was performed to further reduce confounding.
Once group-age had been taken into account, there was a nonsignificant trend for higher levels of EGP in groups with higher mean levels of relatedness between opposite sex adult group members (LMM: χ ( 1 ) 2 = 3.02, P = 0.082, Table 6 ).
The A allele carriers of rs6531975 showed a nonsignificant trend for a reduced prevalence of having fibrosis ( p =0.082) ( Table 3 ).
A nonsignificant trend for endocarditis-related events was also observed in patients withCRP > 16 mg/dL (OR = 7.35; 95%CI: 0.78–69.40; p = 0.082).
The linear model revealed a nonsignificant trend between SNIR and spectral power in the parietal alpha band ( p = 0 . 083 , β SNIR = 0 . 04 ), with the quadratic model yielding a slightly stronger trend ( p = 0 . 067 , β SNIR 2 = − 0 . 009 ).
Although not significantly different, a nonsignificant trend was observed ( p = 0.083, Mann Whitney).
Prior VF showed a nonsignificant trend toward higher discontinuation (HR 1.74, 95% CI 0.93–3.26, P = 0.083).
A nonsignificant trend toward a reduction in the number of antihypertensive drugs was also observed in RD patients (4.78±1.48 [5] at baseline versus 4.35±1.67 [4] at follow‐up, P =0.083).
Patients with PTV < 350 cm 3 had a 26.0% chance for distant recurrence, while patients with PTV ≥ 350 cm 3 had a 39.7% chance for distant recurrence, showing a nonsignificant trend for prediction of distant recurrence, OR 1.87 (95% CI 0.92–3.82), p = 0.083.
Stratified analysis by pathological stage Among patients with pT2 disease, there was a nonsignificant trend toward fewer PSMs in the mpMRI period (unadjusted OR 0.66; 95% CI 0.41–1.05; p = 0.083), which remained nonsignificant after adjustment (adjusted OR 0.71; 95% CI 0.42–1.17; p = 0.20).
We also investigated whether the fMRI correlates of an item’s value or state congruency varied between the first and second item, finding a nonsignificant trend toward a greater effect of state congruency for the first versus second item in the vmPFC (−3, 33, −12; p = .083 FWE SVC).
Subanalyses of the different age ranges showed that the percentages in the deviant range were specifically elevated for children aged 1.5–5 (42 %, p < 0.001), whereas for the older age range (6–18 years), a nonsignificant trend ( p = 0.083) was found.